Cogent Biosciences (COGT) Revenue Growth

Price: $6.01
Market Cap: $684.24M
Avg Volume: 1.36M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.078
52W Range: $5.88-12.61
Website: Cogent Biosciences

What is Cogent Biosciences's Revenue Growth?

  • Cogent Biosciences's annual revenue growth as of FY 2024 is 0.00%.
  • Cogent Biosciences's quarterly revenue growth as of Q4 2024 is 0.00%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess Cogent Biosciences's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $0
    • Quarterly: $0
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $0
    • Quarterly: $0
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: -100.00%
    • Quarterly Growth: 0.00%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $0
    • Quarterly: $0
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: 100.00%
    • Quarterly Growth: 0.00%

These metrics provide insights into Cogent Biosciences's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

0.00%

Quarterly Revenue Growth

0.00%

Historical Annual Revenue Growth
200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%Revenue Growth (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Revenue Growth
20.00%20.00%-0.00%-0.00%-20.00%-20.00%-40.00%-40.00%-60.00%-60.00%-80.00%-80.00%-100.00%-100.00%Revenue Growth (Quarterly)20232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical Annual Revenue
$24.00M$24.00M$18.00M$18.00M$12.00M$12.00M$6.00M$6.00M$0.00$0.00Revenue (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Revenue
$60.00M$60.00M$50.00M$50.00M$40.00M$40.00M$30.00M$30.00M$20.00M$20.00M$10.00M$10.00M$0.00$0.00Revenue (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Annual Cost of Revenue
$6.00M$6.00M$5.00M$5.00M$4.00M$4.00M$3.00M$3.00M$2.00M$2.00M$1.00M$1.00M$0.00$0.00Cost of Revenue (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Cost of Revenue
$40.00M$40.00M$30.00M$30.00M$20.00M$20.00M$10.00M$10.00M$0.00$0.00Cost of Revenue (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Annual Gross Profit
$28.00M$28.00M$21.00M$21.00M$14.00M$14.00M$7.00M$7.00M$0.00$0.00-$7.00M-$7.00MGross Profit (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Gross Profit
$15.00M$15.00M$10.00M$10.00M$5.00M$5.00M$0.00$0.00-$5.00M-$5.00M-$10.00M-$10.00MGross Profit (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025

Cogent Biosciences Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2024 $- 0.00% $- -100.00% $- 100.00%
2023 $- 0.00% $3.59M -38.96% $-3.59M 38.96%
2022 $- 0.00% $5.88M 3898.64% $-5.88M -3898.64%
2021 $- -100.00% $147.00K 471.14% $-147.00K -101.87%
2020 $7.87M -65.02% $25.74K -41.12% $7.85M -65.06%
2019 $22.50M 131.14% $43.71K 0.00% $22.46M 130.69%
2018 $9.73M 16.44% $- 0.00% $9.73M 16.44%
2017 $8.36M 31.55% $- 0.00% $8.36M 31.55%
2016 $6.36M 112.83% $- 0.00% $6.36M 112.83%
2015 $2.99M 0.00% $- 0.00% $2.99M 0.00%

Related Metrics

Explore detailed financial metrics and analysis for COGT.